IL100233A - Medicinal preparations containing esters of castanospermine with anti-herpes activity - Google Patents

Medicinal preparations containing esters of castanospermine with anti-herpes activity

Info

Publication number
IL100233A
IL100233A IL10023391A IL10023391A IL100233A IL 100233 A IL100233 A IL 100233A IL 10023391 A IL10023391 A IL 10023391A IL 10023391 A IL10023391 A IL 10023391A IL 100233 A IL100233 A IL 100233A
Authority
IL
Israel
Prior art keywords
halogen
octahydro
hydrogen
castanospermine
indolizinetetrol
Prior art date
Application number
IL10023391A
Other languages
English (en)
Hebrew (he)
Other versions
IL100233A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL100233A0 publication Critical patent/IL100233A0/xx
Publication of IL100233A publication Critical patent/IL100233A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Dental Preparations (AREA)
IL10023391A 1990-12-18 1991-12-03 Medicinal preparations containing esters of castanospermine with anti-herpes activity IL100233A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909027433A GB9027433D0 (en) 1990-12-18 1990-12-18 Anti-herpes castanospermine esters

Publications (2)

Publication Number Publication Date
IL100233A0 IL100233A0 (en) 1992-09-06
IL100233A true IL100233A (en) 1996-03-31

Family

ID=10687190

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10023391A IL100233A (en) 1990-12-18 1991-12-03 Medicinal preparations containing esters of castanospermine with anti-herpes activity

Country Status (20)

Country Link
US (1) US5385911A (no)
EP (1) EP0492841B1 (no)
JP (1) JPH04342587A (no)
KR (1) KR100192642B1 (no)
AT (1) ATE126435T1 (no)
AU (1) AU643098B2 (no)
CA (1) CA2057821A1 (no)
DE (1) DE69112192T2 (no)
DK (1) DK0492841T3 (no)
ES (1) ES2078462T3 (no)
FI (1) FI915929A (no)
GB (1) GB9027433D0 (no)
GR (1) GR3017152T3 (no)
HU (1) HU210257B (no)
IE (1) IE914400A1 (no)
IL (1) IL100233A (no)
NO (1) NO914986D0 (no)
NZ (1) NZ240976A (no)
PT (1) PT99835B (no)
ZA (1) ZA919808B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466714A (en) * 1987-12-31 1995-11-14 Research Foundation For Mental Health Hygiene, Inc. Spermicidal and cytocidal fatty acid compositions
US5959111A (en) * 1997-05-22 1999-09-28 Hoechst Marion Roussel, Inc. Process for preparing 6-0-monoesters of castanospermine
AU2001234596A1 (en) * 2000-01-28 2001-08-07 Timothy M Block Use of castanospermine and substituted-castanospermine compounds for treating hepatitis virus infections
GB0110832D0 (en) * 2001-05-03 2001-06-27 Virogen Ltd Antiviral compounds
GB0116643D0 (en) * 2001-07-09 2001-08-29 Virogen Ltd Antiviral compounds
US7930711B2 (en) * 2003-03-06 2011-04-19 Wegener Communications, Inc. Apparatus and method for addressing control in a network for distributed data
EP1802327A4 (en) * 2004-10-06 2009-07-15 Migenix Inc COMBINED ANTIVIRAL COMPOSITIONS WITH CASTANOSPERMIN AND METHOD OF USE
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
KR20090040906A (ko) * 2006-08-02 2009-04-27 유나이티드 세러퓨틱스 코오포레이션 바이러스 감염의 리포솜 치료
WO2009118658A2 (en) * 2008-03-26 2009-10-01 University Of Oxford Endoplasmic reticulum targeting liposomes
KR20120059447A (ko) * 2009-03-27 2012-06-08 더 챈슬러 마스터즈 앤드 스칼라스 오브 더 유니버시티 오브 옥스포드 콜레스테롤 수준 저하 리포좀

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760079A (en) * 1983-01-10 1988-07-26 Baltech, Inc. Treatment of diseases caused by herpes viruses
US4628063A (en) * 1984-03-08 1986-12-09 Dana P. Brigham Antiviral pharmaceutical preparations and methods for their use
US4782065A (en) * 1984-04-18 1988-11-01 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US4800081A (en) * 1984-04-18 1989-01-24 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
JPS61227566A (ja) * 1985-04-01 1986-10-09 Fujisawa Pharmaceut Co Ltd スワインソニンおよび関連化合物の合成法
US4751236A (en) * 1987-05-20 1988-06-14 Avihou Mishniot Method for treating genital herpes
US5004746A (en) * 1987-09-29 1991-04-02 Merrell Dow Pharmaceuticals Inc. Anti-retroviral castanospermine esters
US5017563A (en) * 1988-06-23 1991-05-21 Merrell Dow Pharmaceuticals Inc. Castanospermine esters and glycosides

Also Published As

Publication number Publication date
PT99835A (pt) 1992-12-31
IL100233A0 (en) 1992-09-06
HUT59924A (en) 1992-07-28
NZ240976A (en) 1997-03-24
FI915929A0 (fi) 1991-12-17
US5385911A (en) 1995-01-31
JPH04342587A (ja) 1992-11-30
ES2078462T3 (es) 1995-12-16
FI915929A (fi) 1992-06-19
ATE126435T1 (de) 1995-09-15
PT99835B (pt) 1999-06-30
EP0492841A1 (en) 1992-07-01
HU210257B (en) 1995-03-28
KR920011488A (ko) 1992-07-24
ZA919808B (en) 1992-09-30
GB9027433D0 (en) 1991-02-06
AU8964191A (en) 1992-06-25
DE69112192T2 (de) 1996-04-04
KR100192642B1 (ko) 1999-06-15
DE69112192D1 (de) 1995-09-21
AU643098B2 (en) 1993-11-04
GR3017152T3 (en) 1995-11-30
IE914400A1 (en) 1992-07-01
EP0492841B1 (en) 1995-08-16
DK0492841T3 (da) 1995-09-18
NO914986D0 (no) 1991-12-17
HU913989D0 (en) 1992-03-30
CA2057821A1 (en) 1992-06-19

Similar Documents

Publication Publication Date Title
KR100488429B1 (ko) 포스포디에스테라제 ｖ 억제효과를 가지는 티에노피리미딘
AU775993B2 (en) Imidazopyridine derivatives as phosphodiesterase VII inhibitors
EP0492841B1 (en) Anti-herpes castanospermine esters
EP0309952B1 (en) Anti-retroviral castanospermine esters
WO2002041896A2 (de) Verwendung von thienopyrimidinen
EP1210349B1 (de) Pyrazolo[4, 3-d]pyrimidine
EP1084125B1 (de) Kondensierte thienopyrimidine mit pde v inhibierender wirkung
HU206264B (en) Process for producing synergic pharmaceutical compositions comprising antiviral compound and ribonucleotide reductase inhibitor or salts thereof, as well as for producing ribonucleotide reductase inhibitor
EP1857108B1 (en) Preventive or therapeutic agent for herpesvirus-related disease
US6911460B2 (en) Antiviral agents and methods of treating viral infections
EP1357904A2 (de) Verwendung von pyrazolo 4,3-d]pyrimidinen
KR20080014017A (ko) (5ｚ)-5-(6-퀴녹살리닐메틸리덴)-2-[(2,6-디클로로페닐)아미노]-1,3-티아졸-4(5ｈ)-온
EP1351962B1 (de) Thienopyrimidine
EP1844776B1 (en) Agent for prevention/treatment of disease caused by acyclovir-resistant herpesvirus
WO2001019369A1 (de) Verwendung von thienopyrimidinen
WO1993015717A1 (en) Compositions for the treatment of glaucoma
CN114539142A (zh) 吡啶酮类化合物，其药物组合物、制备方法和应用
EP0423728A2 (en) Esters of castanospermine in the treatment of cerebral malaria

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees